RecruitingNot ApplicableNCT04515810

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Planning Advance Care Together (PACT) to Improve Engagement in Advance Care Planning

Sponsor

Fred Hutchinson Cancer Center

Enrollment

400 participants

Start Date

Feb 18, 2025

Study Type

INTERVENTIONAL

Conditions

Locally Advanced Malignant Solid Neoplasm Metastatic Malignant Solid Neoplasm Refractory Hematologic Malignancy Recurrent Hematologic Malignancy

Summary

This clinical trial tests a new mobile health application (app) called Planning Advance Care Together (PACT) to help people with cancer talk about and plan for advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors. The development of the PACT mobile app may help future patients incorporate their social network (typically, but not exclusively, family) into the advance care planning process.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Best Practice, Internet-Based Intervention, and others for people with locally advanced malignant solid neoplasm, metastatic malignant solid neoplasm, and other related conditions. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERInternet-Based Intervention

Use smartphone application

OTHERBest Practice

Engage in standard care

OTHERTelephone-Based Intervention

Receive check-in call

OTHERQuestionnaire Administration

Ancillary studies

OTHERPost-intervention qualitative feedback interview

Post-intervention qualitative feedback interview (with a subset of patients and support persons)

Locations(4)

Northwell Health

Manhasset, New York, United States

Mount Sinai Hospital

New York, New York, United States

NYP/Weill Cornell Medical Center

New York, New York, United States

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04515810

Related Trials

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

NCT0537261418 locations

Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

NCT039074751 location

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

NCT05564377483 locations

Imaging of Solid Tumors Using 18F-TRX

NCT069421041 location

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

NCT043294943 locations